PH17006A - Pharmacollogically active peptides - Google Patents

Pharmacollogically active peptides

Info

Publication number
PH17006A
PH17006A PH26344A PH26344A PH17006A PH 17006 A PH17006 A PH 17006A PH 26344 A PH26344 A PH 26344A PH 26344 A PH26344 A PH 26344A PH 17006 A PH17006 A PH 17006A
Authority
PH
Philippines
Prior art keywords
pharmacollogically
active peptides
peptides
active
pharmacollogically active
Prior art date
Application number
PH26344A
Other languages
English (en)
Inventor
Gesellchen Paul David
Shuman Robert Theodore
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH17006A publication Critical patent/PH17006A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PH26344A 1980-10-20 1981-10-13 Pharmacollogically active peptides PH17006A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/198,900 US4322340A (en) 1980-10-20 1980-10-20 Pharmacologically active peptides

Publications (1)

Publication Number Publication Date
PH17006A true PH17006A (en) 1984-05-11

Family

ID=22735344

Family Applications (1)

Application Number Title Priority Date Filing Date
PH26344A PH17006A (en) 1980-10-20 1981-10-13 Pharmacollogically active peptides

Country Status (27)

Country Link
US (1) US4322340A (da)
EP (1) EP0050502B1 (da)
JP (1) JPS57108052A (da)
KR (1) KR830007518A (da)
AR (1) AR230046A1 (da)
AT (1) ATE6777T1 (da)
AU (1) AU547221B2 (da)
BG (1) BG36928A3 (da)
CA (1) CA1187871A (da)
DD (1) DD200798A5 (da)
DE (1) DE3162823D1 (da)
DK (1) DK461481A (da)
ES (1) ES506316A0 (da)
FI (1) FI813198L (da)
GB (1) GB2085893B (da)
GR (1) GR75342B (da)
HU (1) HU185320B (da)
IE (1) IE52186B1 (da)
IL (1) IL64083A (da)
NZ (1) NZ198628A (da)
PH (1) PH17006A (da)
PL (1) PL131155B1 (da)
PT (1) PT73839B (da)
RO (1) RO83301B (da)
SU (1) SU1082319A3 (da)
YU (1) YU249081A (da)
ZA (1) ZA817063B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE16495T1 (de) * 1981-06-22 1985-11-15 Ici Plc Peptide und pseudopeptide, die zwei substituenten am n-terminus aufweisen.
US4448717A (en) * 1982-11-12 1984-05-15 Eli Lilly And Company Pharmacologically active peptides
US4473497A (en) * 1983-03-07 1984-09-25 Eli Lilly And Company Pharmacologically active peptides
US4510082A (en) * 1983-03-07 1985-04-09 Eli Lilly And Company Pharmacologically active peptides
DK134784A (da) * 1983-03-07 1984-09-08 Lilly Co Eli Farmakologisk virksomme tripeptid-derivater og fremgangsmaade til fremstilling deraf
US4495178A (en) * 1983-10-06 1985-01-22 G. D. Searle & Co. Enkephalin analogs
JPH0449298A (ja) * 1990-06-19 1992-02-18 Univ New York State 新規なエンケファリン誘導体および鎮痛剤
US5209930A (en) * 1990-12-10 1993-05-11 Rohm And Haas Company Preparation and use of n-iodopropargyl oxycarbonyl amino acid esters and derivatives as antimicrobial agents
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
CA2161108A1 (en) * 1993-04-23 1994-11-10 Herbert J. Evans Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1577115A (en) * 1976-07-27 1980-10-22 Reckitt & Colmann Prod Ltd Container closure units
FI770219A (da) * 1976-02-02 1977-08-03 Sandoz Ag
CH619686A5 (en) * 1976-02-02 1980-10-15 Sandoz Ag Process for the preparation of novel peptides or peptide derivatives
US4264491A (en) * 1977-10-03 1981-04-28 Eli Lilly And Company Analgesic compounds
US4265808A (en) * 1979-12-17 1981-05-05 Eli Lilly And Company Pharmacologically active peptides

Also Published As

Publication number Publication date
CA1187871A (en) 1985-05-28
EP0050502B1 (en) 1984-03-21
PL233498A1 (da) 1982-05-24
AU547221B2 (en) 1985-10-10
PT73839A (en) 1981-11-01
GB2085893B (en) 1984-03-21
JPS57108052A (en) 1982-07-05
ZA817063B (en) 1983-05-25
DD200798A5 (de) 1983-06-15
FI813198L (fi) 1982-04-21
IE812442L (en) 1982-04-20
ATE6777T1 (de) 1984-04-15
RO83301B (ro) 1984-02-28
BG36928A3 (en) 1985-02-15
PL131155B1 (en) 1984-10-31
SU1082319A3 (ru) 1984-03-23
YU249081A (en) 1983-12-31
ES8306713A1 (es) 1983-06-01
RO83301A (ro) 1984-02-21
EP0050502A1 (en) 1982-04-28
GB2085893A (en) 1982-05-06
PT73839B (en) 1983-01-17
US4322340A (en) 1982-03-30
IE52186B1 (en) 1987-08-05
IL64083A0 (en) 1982-01-31
AR230046A1 (es) 1984-02-29
DK461481A (da) 1982-04-21
HU185320B (en) 1985-01-28
NZ198628A (en) 1985-01-31
IL64083A (en) 1985-03-31
KR830007518A (ko) 1983-10-21
DE3162823D1 (en) 1984-04-26
ES506316A0 (es) 1983-06-01
GR75342B (da) 1984-07-13
AU7657481A (en) 1982-04-29

Similar Documents

Publication Publication Date Title
GB2080682B (en) Antiherpetically active lipstick
GB8313215D0 (en) Peptides
GB2134908B (en) Polypeptide active immunosuppressant fraction
DE3375143D1 (en) Peptides
PH17006A (en) Pharmacollogically active peptides
DE3377654D1 (en) Hypocholesterolemically active protein
JPS56167698A (en) Most desirable polypeptide prduction
AU542630B2 (en) Peptides
JPS5697255A (en) Pharmacutically active peptides
JPS5697256A (en) Pharmacutically active peptides
GB2075516B (en) Anorexigenic peptides
GB2130590B (en) Peptides
GB2086396B (en) Biologically active peptides
ZA837454B (en) Peptides
JPS55149237A (en) Thymopoietin active peptide
GB2118190B (en) Peptides with sauvagine-like activity
ZA838315B (en) Peptides
CU35465A (en) Active matter combination
IE800527L (en) Peptides
IE802518L (en) Adamantane-substituted peptides
IE802013L (en) Peptides
IE802103L (en) Phosphonylmuramyl peptides
AU547212B2 (en) Peptides
IE822794L (en) Peptides
IE822432L (en) Peptides